Robotic segmentectomy improves long-term survival in non-small cell lung cancer, highlighting surgical advantages.
RATS segmentectomy demonstrated improved survival metrics and reduced recurrence compared with VATS while maintaining comparable perioperative outcomes. The robotic platform facilitated more extensive lymphadenectomy and wider resection margins, which may underlie the observed oncologic advantages.
No takes yet. Share an insight, caveat, or question.
Berjaoui et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: